Agrobacterium tumefaciens is a soil-dwelling bacterium with a remarkable ability: it can insert its own DNA into plant cells, effectively reprogramming them. In nature, this causes a plant disease called crown gall, which produces tumor-like growths on stems and roots. In the laboratory, scientists have harnessed that same DNA-transfer trick to create genetically modified crops, making this single organism both a plant pathogen and one of the most important tools in modern biotechnology.
Basic Biology and Classification
A. tumefaciens is a Gram-negative bacterium in the family Rhizobiaceae, part of the broader Alphaproteobacteria group. It lives naturally in soil, where it can form biofilms on plant surfaces and in the surrounding environment. Taxonomists have actually reclassified it as Rhizobium radiobacter, reflecting genetic evidence that Agrobacterium species are closely related to nitrogen-fixing Rhizobium bacteria. In practice, most researchers and textbooks still use the name Agrobacterium tumefaciens, and you’ll encounter both names in scientific literature.
The bacterium senses its environment through a chemical navigation system distinct from the one used by more familiar bacteria like E. coli. It’s drawn toward wounded plants by specific chemical signals, which is the first step in its infection cycle.
How It Infects Plants
The infection process begins when a plant is wounded. Damaged plant tissue releases phenolic compounds (acetosyringone was the first one identified) along with sugars, and the local environment around the wound becomes more acidic. A. tumefaciens detects these signals through sensor proteins on its surface, which switch on a set of genes called virulence (vir) genes. These genes encode all the molecular machinery the bacterium needs to transfer DNA into the plant.
The DNA that gets transferred comes from a large circular piece of DNA the bacterium carries called the Ti plasmid (Ti stands for “tumor-inducing”). A specific region of this plasmid, called the T-DNA, is processed into a single strand, and a protein called VirD2 attaches to one end of it. This protein-DNA package, along with several other bacterial proteins, is then injected into the plant cell through a needle-like structure called a Type IV Secretion System.
Once inside the plant cell, the T-DNA is shuttled into the nucleus and integrated directly into the plant’s own chromosomes. At that point, the plant cell reads and follows the bacterial instructions as if they were its own genes. The entire process, from wound detection to DNA integration, is essentially a natural form of genetic engineering that evolved long before humans entered the picture.
Crown Gall Disease
The wild-type T-DNA carries genes that do two things to the plant. First, it forces the plant cell to overproduce growth hormones, causing uncontrolled cell division. This creates the characteristic galls: irregular, tumor-like masses that appear on stems, roots, and especially at the soil line where the stem meets the ground. New galls are light-colored, round, and slightly spongy. Older ones turn dark, harden, and develop rough cracks and fissures. They can range from a tenth of an inch to a foot across.
Second, the T-DNA instructs the plant cell to produce unusual compounds called opines. These are modified amino acids that the plant cannot use but that A. tumefaciens can break down for carbon, nitrogen, phosphorus, and even sulfur. The bacterium essentially remodels the plant cell into a private food factory. Different strains direct the production of different opines, and each strain carries the genes to consume the specific opines it programs the plant to make.
Crown gall affects more than 600 plant species worldwide. It’s commonly seen on roses, willows, poplars, and fruit trees like apple, cherry, plum, and apricot. The disease weakens plants and can be economically damaging in nurseries and orchards, though it rarely kills mature trees outright.
Why It Matters for Genetic Engineering
In the early 1980s, researchers realized they could strip the tumor-causing and opine-producing genes out of the T-DNA and replace them with any gene they wanted to introduce into a plant. The bacterium’s transfer machinery doesn’t care what’s between the T-DNA border sequences. It will faithfully deliver whatever DNA is placed there into the plant cell’s chromosomes.
This led to the development of “disarmed” strains, bacteria that retain the ability to transfer DNA but no longer cause tumors or produce opines. Scientists split the system into two parts: one plasmid carries the virulence genes (the transfer machinery), while a separate, smaller plasmid called a binary vector carries the T-DNA with the gene of interest. Because binary vectors are small and easy to work with in standard lab bacteria like E. coli, this system opened up plant genetic engineering to laboratories worldwide.
Modern binary vectors typically include border sequences that define the T-DNA, a selectable marker gene (often for antibiotic or herbicide resistance, so researchers can identify which plant cells successfully received the new DNA), and a cloning site where the desired gene is inserted. The selectable marker is usually placed near one end of the T-DNA to ensure the gene of interest transfers completely.
Originally, Agrobacterium-mediated transformation worked best in broad-leaved plants like tobacco, tomato, and potato. A major breakthrough came when researchers figured out how to use it on grasses and cereal crops. Today, cultivars of maize, rice, barley, and wheat are routinely transformed using Agrobacterium. This technique is the foundation behind many commercially grown genetically modified crops, from herbicide-tolerant soybeans to insect-resistant cotton.
Can It Affect Humans?
A. tumefaciens is primarily a plant pathogen, and healthy people face essentially no risk from it. However, it has been documented as a rare opportunistic pathogen in immunocompromised patients, particularly those with indwelling catheters or central venous lines. A study covering bacteremia cases in Switzerland from 2008 to 2019 identified only eight episodes caused by Agrobacterium species over that entire period. Reported human infections are overwhelmingly bloodstream infections in cancer patients or others with severely weakened immune systems. For the general population, this bacterium poses no health concern.